GO:0002944 cyclin K-CDK12 complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002944 describes the cyclin K-CDK12 complex, a cellular component consisting of cyclin K and cyclin-dependent kinase 12 (CDK12).
• The complex maintains genomic stability by regulating expression of DNA damage response genes.
• Inhibition of the cyclin K-CDK12 complex induces DNA damage and can increase the effect of androgen deprivation therapy in prostate cancer.
• Cyclin K acts as the regulatory partner that activates CDK12, a serine/threonine kinase.
• Dysregulation of the complex is linked to cancer, particularly prostate cancer, and genome instability.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are key tools to study this complex.
Description
The cyclin K-CDK12 complex (GO:0002944) is a protein complex that plays a critical role in maintaining genome stability. It consists of cyclin K and cyclin-dependent kinase 12 (CDK12), a member of the cyclin-dependent kinase family. This complex is essential for the proper regulation of gene expression, particularly for genes involved in the DNA damage response. Understanding its function is crucial for researchers studying cancer biology, as inhibition of this complex has been shown to induce DNA damage and enhance the effects of androgen deprivation therapy in prostate cancer. The complex is also a target for therapeutic intervention, making it a focus of ongoing biomedical research.
cyclin K-CDK12 complex At A Glance
| GO ID | GO:0002944 |
|---|---|
| GO term | cyclin K-CDK12 complex |
| Ontology | cellular_component |
| Synonym | CycK/Cdk12 complex |
| Major function | Maintains genomic stability via regulation of DNA damage response genes |
| Complex components | Cyclin K and CDK12 |
| Associated disease | Prostate cancer |
| Research relevance | Target for cancer therapy and genome stability studies |
What Is GO:0002944?
The cyclin K-CDK12 complex is a cellular component defined by the Gene Ontology as a protein complex consisting of cyclin K and cyclin-dependent kinase 12 (CDK12). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle, and cyclin-dependent kinases are a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner. This complex is also known by the synonym CycK/Cdk12 complex.
Why Is cyclin K-CDK12 complex Important in Cell Biology?
The cyclin K-CDK12 complex is important because it maintains genomic stability by regulating the expression of DNA damage response genes. Its inhibition induces DNA damage and can sensitize prostate cancer cells to androgen deprivation therapy, highlighting its potential as a therapeutic target. Furthermore, understanding this complex provides insights into fundamental mechanisms of transcription regulation and cell cycle control.
• Maintains genomic stability through regulation of DNA damage response genes.
• Inhibition induces DNA damage and enhances androgen deprivation therapy in prostate cancer.
• Cyclin K activates CDK12, a serine/threonine kinase.
• Dysregulation is linked to cancer and genome instability.
• Potential therapeutic target for prostate cancer.
• Involved in transcription regulation and cell cycle control.
• Studied using CRISPR knockout, point mutation, knock-in, and overexpression models.
• Key for understanding DNA repair mechanisms.
Structure and Composition of cyclin K-CDK12 complex
Cyclin K subunit
In simple terms: Cyclin K is the regulatory partner that activates CDK12.
Cyclin K is a cyclin protein characterized by periodicity in abundance throughout the cell cycle. It binds to and activates CDK12, forming the cyclin K-CDK12 complex.
CDK12 subunit
In simple terms: CDK12 is the kinase enzyme that adds phosphate groups to target proteins.
CDK12 is a cyclin-dependent kinase, a serine/threonine protein kinase that becomes active upon binding to cyclin K. It phosphorylates substrates involved in DNA damage response and transcription.
Complex assembly
In simple terms: Cyclin K and CDK12 come together to form a functional complex.
The cyclin K-CDK12 complex assembles through the binding of cyclin K to CDK12, which activates the kinase domain of CDK12. This assembly is essential for the complex's role in maintaining genomic stability.
Subcellular localization
In simple terms: The complex works in the nucleus to control gene expression.
The cyclin K-CDK12 complex localizes to the nucleus, where it regulates the expression of DNA damage response genes.
Key Genes Involved in GO:0002944 cyclin K-CDK12 complex
The following genes and proteins are key components or regulators of the cyclin K-CDK12 complex and its associated functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCNK | Encodes cyclin K, regulatory subunit of the complex | Essential for CDK12 activation and complex formation |
| CDK12 | Encodes CDK12, catalytic kinase subunit | Phosphorylates substrates in DNA damage response |
| CDK13 | Paralog of CDK12, may compensate in some contexts | Potential redundancy in complex functions |
| BRCA1 | DNA damage response gene regulated by the complex | Expression controlled by cyclin K-CDK12 |
| BRCA2 | DNA damage response gene regulated by the complex | Expression controlled by cyclin K-CDK12 |
| ATM | DNA damage response gene regulated by the complex | Expression controlled by cyclin K-CDK12 |
| ATR | DNA damage response gene regulated by the complex | Expression controlled by cyclin K-CDK12 |
| TP53 | Tumor suppressor, may interact with complex pathways | Potential crosstalk in cancer |
| AR | Androgen receptor, target in prostate cancer | Complex inhibition enhances ADT effect |
| POLR2A | RNA polymerase II subunit, involved in transcription | Potential substrate of CDK12 |
| SUPT5H | Transcription elongation factor | Potential CDK12 substrate |
| XRN2 | Transcription termination factor | Potential CDK12 substrate |
| RAD51 | DNA repair gene | Expression may be regulated by complex |
| CHEK1 | DNA damage checkpoint kinase | Expression may be regulated by complex |
| CHEK2 | DNA damage checkpoint kinase | Expression may be regulated by complex |
| FANCD2 | Fanconi anemia DNA repair protein | Expression may be regulated by complex |
| MDC1 | Mediator of DNA damage checkpoint | Expression may be regulated by complex |
How Is cyclin K-CDK12 complex Regulated?
The cyclin K-CDK12 complex is regulated by the availability of its subunits, particularly cyclin K, which is periodically expressed during the cell cycle. Its kinase activity is dependent on cyclin K binding. Additionally, the complex's function in DNA damage response gene expression is critical for genome stability, and its dysregulation can lead to cancer.
cyclin K-CDK12 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDK12 | Prostate cancer | Knockout or point mutation in prostate cancer cell lines |
| CCNK | Genome instability | Knockout in cancer cell lines |
| CDK12 | DNA damage response defects | Knockout in HeLa or U2OS cells |
| CCNK | Transcription regulation | Overexpression or knockdown |
| CDK12 | Androgen deprivation therapy response | Combination with ADT in xenograft models |
Prostate cancer
Inhibition of the cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer. This suggests that targeting the complex could be a therapeutic strategy for prostate cancer.
Genome instability and cancer predisposition
The cyclin K-CDK12 complex maintains genomic stability by regulating DNA damage response genes. Loss of its function leads to impaired DNA repair and genome instability, which are hallmarks of cancer.
From cyclin K-CDK12 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CDK12 affect DNA damage response? | CDK12 knockout cell lines |
| Does cyclin K-CDK12 inhibition enhance ADT? | Prostate cancer xenografts with CDK12 inhibitor |
| What are the substrates of CDK12? | Point mutation of CDK12 kinase domain |
| How does cyclin K binding regulate CDK12? | Knock-in of tagged cyclin K |
| Does overexpression of cyclin K drive cancer? | Cyclin K overexpression models |
| Can CRISPR screening identify synthetic lethal partners? | CRISPR library screening in CDK12-mutant cells |
How to Study the cyclin K-CDK12 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotypes | Study DNA damage response and cancer |
| RNA-seq | Gene expression changes | Identify DNA damage response genes regulated by complex |
| Co-immunoprecipitation | Protein-protein interactions | Confirm cyclin K-CDK12 assembly |
| Proteomics | Substrate identification | Find CDK12 substrates |
| CRISPR library screening | Synthetic lethal interactions | Identify combination therapies |
| Western blot | Protein expression and phosphorylation | Validate knockout and inhibitor effects |
| Immunofluorescence | Subcellular localization | Determine nuclear localization |
| Flow cytometry | Cell cycle and DNA damage | Measure genomic instability |
CRISPR knockout
CRISPR knockout of CDK12 or CCNK is used to study loss-of-function phenotypes, such as DNA damage sensitivity and effects on androgen deprivation therapy.
Proteomics and co-immunoprecipitation
Proteomic approaches can identify interacting partners and substrates of the cyclin K-CDK12 complex.
RNA sequencing
RNA-seq measures changes in gene expression, particularly DNA damage response genes, upon complex inhibition.
CRISPR library screening
Genome-wide CRISPR screens can identify genes that are synthetic lethal with CDK12 loss, revealing potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0002944 cyclin K-CDK12 complex
Knockout
CRISPR knockout of CDK12 or CCNK generates cell models to study the loss of cyclin K-CDK12 complex function, leading to DNA damage sensitivity and impaired DNA damage response.
Point Mutation
Point mutations in the kinase domain of CDK12 can be introduced to study its catalytic activity and substrate specificity.
Knock-in
Knock-in of tagged cyclin K or CDK12 allows for affinity purification and localization studies of the complex.
Overexpression
Overexpression of cyclin K or CDK12 can be used to study gain-of-function effects, such as oncogenic transformation.
How EDITGENE Supports cyclin K-CDK12 complex Research
Researchers studying cyclin K-CDK12 complex-related genes often need to determine whether a candidate gene is causally involved in genome stability, cancer progression, or therapy response. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cyclin K-CDK12 complex research.
Frequently Asked Questions About cyclin K-CDK12 complex
What is the cyclin K-CDK12 complex?
The cyclin K-CDK12 complex is a protein complex consisting of cyclin K and CDK12 that maintains genomic stability by regulating DNA damage response genes.
What genes are involved in the cyclin K-CDK12 complex?
The main genes are CCNK (cyclin K) and CDK12 (cyclin-dependent kinase 12).
What is the function of GO:0002944?
GO:0002944 represents the cellular component cyclin K-CDK12 complex, which functions in DNA damage response and genome stability.
How is the cyclin K-CDK12 complex regulated?
It is regulated by cyclin K availability and binding, which activates CDK12 kinase activity.
What diseases are associated with cyclin K-CDK12 complex?
Dysregulation is linked to prostate cancer and genome instability.
How can I study the cyclin K-CDK12 complex?
CRISPR knockout, point mutation, knock-in, overexpression, and CRISPR library screening are common methods.
What is the role of CDK12 in cancer?
CDK12 inhibition induces DNA damage and enhances androgen deprivation therapy in prostate cancer.
What is cyclin K?
Cyclin K is a regulatory subunit that binds and activates CDK12.
What are the substrates of CDK12?
CDK12 phosphorylates proteins involved in DNA damage response and transcription, such as RNA polymerase II.
How does the cyclin K-CDK12 complex maintain genome stability?
It regulates the expression of DNA damage response genes, ensuring proper DNA repair.
Conclusion
The cyclin K-CDK12 complex (GO:0002944) is a critical regulator of genome stability and a promising target in cancer therapy. Understanding its structure, function, and regulation provides insights into fundamental cellular processes and disease mechanisms. CRISPR-based models are invaluable for dissecting its roles and identifying therapeutic strategies.
References
- 1. Frei K et al.. 2024. Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer.. Int J Cancer 154(6):1082-1096 PMID: 37916780
- 2. Blazek D. 2012. The cyclin K/Cdk12 complex: an emerging new player in the maintenance of genome stability.. Cell Cycle 11(6):1049-50 PMID: 22391210
- 3. Blazek D et al.. 2011. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes.. Genes Dev 25(20):2158-72 PMID: 22012619
